ASP Isotopes Inc. Common Stock (ASPI) 10-Year Financial Performance & Capital Metrics

ASPI • • Industrial / General

Basic MaterialsChemicalsIsotopes & Advanced MaterialsMedical & Energy Isotopes

AboutASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.Show more

Revenue $4M +857.0%
EBITDA -$26M -61.7%
Net Income -$32M -98.5%
EPS (Diluted) -0.63 -28.6%
Gross Margin 38.6% +20.3%
EBITDA Margin -624.54% +83.1%
Operating Margin -635.91% +82.8%
Net Margin -780.21% +79.3%
ROE -92.39% +18.7%
ROIC -98.61% +12.6%
Debt/Equity 0.74 +548.3%
Interest Coverage -101.80 +24.8%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Negative free cash flow
✗Shares diluted 68.4% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM147.78%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-286.48%

EPS CAGR

10Y-

5Y-

3Y-

TTM-140.21%

ROCE

10Y Avg-58.84%

5Y Avg-58.84%

3Y Avg-65.74%

Latest-47.14%

Peer Comparison

Medical & Energy Isotopes

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
FMSTWForemost Lithium Resource & Technology Ltd.		0.77	-1.61			-10.57%	0.02
FMSTForemost Clean Energy Ltd.	31.47M	2.18	-4.54			-10.57%	0.02
ASPIASP Isotopes Inc. Common Stock	935.82M	7.48	-11.87	8.57%	-12.59%	-109.28%	0.74

Profit & Loss

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	433.03K	4.14M
Revenue Growth %	-	-	-	8.57%
Cost of Goods Sold+	19.38K	72.57K	294.06K	2.54M
COGS % of Revenue	-	-	0.68%	0.61%
Gross Profit+	-19.38K	-72.57K	138.97K	1.6M
Gross Margin %	-	-	0.32%	0.39%
Gross Profit Growth %	-	-2.75%	2.91%	10.51%
Operating Expenses+	2.59M	5.1M	16.18M	27.95M
OpEx % of Revenue	-	-	37.37%	6.75%
Selling, General & Admin	2.55M	3.83M	15.42M	24.81M
SG&A % of Revenue	-	-	35.6%	5.99%
Research & Development	41.61K	1.27M	764.58K	3.14M
R&D % of Revenue	-	-	1.77%	0.76%
Other Operating Expenses	0	0	0	0
Operating Income+	-2.61M	-5.1M	-16.04M	-26.35M
Operating Margin %	-	-	-37.05%	-6.36%
Operating Income Growth %	-	-0.96%	-2.15%	-0.64%
EBITDA+	-2.59M	-5.03M	-16M	-25.88M
EBITDA Margin %	-	-	-36.96%	-6.25%
EBITDA Growth %	-	-0.94%	-2.18%	-0.62%
D&A (Non-Cash Add-back)	19.38K	72.57K	37.43K	471.42K
EBIT	-2.61M	-4.95M	-16.18M	-32.05M
Net Interest Income+	115	3.38K	-109.47K	979.82K
Interest Income	115	3.38K	9.07K	1.24M
Interest Expense	0	0	118.55K	258.87K
Other Income/Expense	113	153.91K	-258.26K	-5.96M
Pretax Income+	-2.61M	-4.95M	-16.3M	-32.31M
Pretax Margin %	-	-	-37.64%	-7.8%
Income Tax+	0	0	-6.13K	111.45K
Effective Tax Rate %	1%	0.97%	1%	1%
Net Income+	-2.61M	-4.79M	-16.29M	-32.33M
Net Margin %	-	-	-37.61%	-7.8%
Net Income Growth %	-	-0.84%	-2.4%	-0.99%
Net Income (Continuing)	-2.61M	-4.95M	-16.29M	-32.42M
Discontinued Operations	0	0	0	0
Minority Interest	0	0	2.53M	3.27M
EPS (Diluted)+	-0.08	-0.13	-0.49	-0.63
EPS Growth %	-	-0.71%	-2.77%	-0.29%
EPS (Basic)	-0.08	-0.13	-0.49	-0.63
Diluted Shares Outstanding	34.36M	35.91M	33.07M	55.67M
Basic Shares Outstanding	34.36M	35.91M	33.07M	55.67M
Dividend Payout Ratio	-	-	-	-

Balance Sheet

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	3.22M	3.3M	10.51M	65.74M
Cash & Short-Term Investments	2.95M	2.39M	7.91M	61.89M
Cash Only	2.95M	2.39M	7.91M	61.89M
Short-Term Investments	0	0	0	0
Accounts Receivable	0	0	938.05K	734.48K
Days Sales Outstanding	-	-	790.69	64.69
Inventory	0	0	0	65.66K
Days Inventory Outstanding	-	-	-	9.42
Other Current Assets	0	913K	1.66M	3.05M
Total Non-Current Assets+	3.92M	9.19M	19.68M	28.6M
Property, Plant & Equipment	3.92M	9.05M	11.97M	23.48M
Fixed Asset Turnover	-	-	0.04x	0.18x
Goodwill	0	0	3.27M	3.17M
Intangible Assets	0	0	0	0
Long-Term Investments	0	0	0	0
Other Non-Current Assets	0	139.64K	4.44M	-3.81M
Total Assets+	7.14M	12.5M	30.19M	94.35M
Asset Turnover	-	-	0.01x	0.04x
Asset Growth %	-	0.75%	1.42%	2.13%
Total Current Liabilities+	303.35K	1.94M	5.67M	7.06M
Accounts Payable	59.68K	1.35M	1.11M	1.02M
Days Payables Outstanding	1.12K	6.81K	1.38K	146.51
Short-Term Debt	46.9K	33.85K	470.4K	939.11K
Deferred Revenue (Current)	42.5K	0	882K	882K
Other Current Liabilities	116.2K	140.46K	1.97M	1.26M
Current Ratio	10.62x	1.71x	1.85x	9.31x
Quick Ratio	10.62x	1.71x	1.85x	9.31x
Cash Conversion Cycle	-	-	-	-72.4
Total Non-Current Liabilities+	841.62K	742.44K	5.68M	41.87M
Long-Term Debt	0	0	0	34.87M
Capital Lease Obligations	841.62K	742.44K	1.27M	1.25M
Deferred Tax Liabilities	0	0	110.58K	0
Other Non-Current Liabilities	0	0	4.3M	5.74M
Total Liabilities	1.14M	2.68M	11.36M	43.18M
Total Debt+	926.6K	822.2K	2.14M	37.75M
Net Debt	-2.03M	-1.57M	-5.77M	-24.14M
Debt / Equity	0.15x	0.08x	0.11x	0.74x
Debt / EBITDA	-	-	-	-
Net Debt / EBITDA	-	-	-	-
Interest Coverage	-	-	-135.32x	-101.80x
Total Equity+	6M	9.82M	18.83M	51.17M
Equity Growth %	-	0.64%	0.92%	1.72%
Book Value per Share	0.17	0.27	0.57	0.92
Total Shareholders' Equity	6M	9.82M	16.3M	47.9M
Common Stock	206.53K	359.07K	489.23K	720.68K
Retained Earnings	-2.61M	-7.55M	-23.84M	-56.17M
Treasury Stock	0	0	0	0
Accumulated OCI	18.72K	255.03K	-920.98K	-2.16M
Minority Interest	0	0	2.53M	3.27M

Cash Flow

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-577.69K	-2.94M	-5.41M	-16.7M
Operating CF Margin %	-	-	-12.5%	-4.03%
Operating CF Growth %	-	-4.09%	-0.84%	-2.08%
Net Income	-2.61M	-4.95M	-16.29M	-32.42M
Depreciation & Amortization	19.38K	72.57K	37.43K	471.42B
Stock-Based Compensation	0	2M	8.74M	8.56M
Deferred Taxes	0	-72.57K	16.66K	-143.28K
Other Non-Cash Items	2.23M	-27.96K	924.12K	-471.41B
Working Capital Changes	-238.21K	33.89K	1.16M	-2.62M
Change in Receivables	0	0	237.95K	-505.95K
Change in Inventory	0	0	0	-67.64K
Change in Payables	59.68K	570.6K	-224.6K	-877.47K
Cash from Investing+	-2.99M	-4.47M	-2.45M	-11.37M
Capital Expenditures	-2.99M	-4.47M	-2.33M	-11.37M
CapEx % of Revenue	-	-	5.38%	2.74%
Acquisitions	-	-	-	-
Investments	-	-	-	-
Other Investing	0	0	0	0
Cash from Financing+	6.5M	6.64M	13.39M	82.53M
Debt Issued (Net)	-	-	-	-
Equity Issued (Net)	-	-	-	-
Dividends Paid	0	0	0	-2.78T
Share Repurchases	-	-	-	-
Other Financing	0	-1.47M	-563.47K	2.78T
Net Change in Cash	-	-	-	-
Free Cash Flow+	-3.57M	-7.41M	-7.74M	-28.07M
FCF Margin %	-	-	-17.88%	-6.77%
FCF Growth %	-	-1.08%	-0.04%	-2.62%
FCF per Share	-0.10	-0.21	-0.23	-0.50
FCF Conversion (FCF/Net Income)	0.22x	0.61x	0.33x	0.52x
Interest Paid	0	0	0	0
Taxes Paid	0	0	0	0

Key Ratios

Metric	2021	2022	2023	2024
Return on Equity (ROE)	-43.48%	-60.59%	-113.7%	-92.39%
Return on Invested Capital (ROIC)	-	-62.59%	-112.89%	-98.61%
Gross Margin	-	-	32.09%	38.6%
Net Margin	-	-	-3761.03%	-780.21%
Debt / Equity	0.15x	0.08x	0.11x	0.74x
Interest Coverage	-	-	-135.32x	-101.80x
FCF Conversion	0.22x	0.61x	0.33x	0.52x
Revenue Growth	-	-	-	857.04%

Revenue by Segment

	2024
Product	3.94M
Product Growth	-
Collaboration Revenue	200K
Collaboration Revenue Growth	-

Frequently Asked Questions

Growth & Financials

ASP Isotopes Inc. Common Stock (ASPI) reported $8.4M in revenue for fiscal year 2024.

ASP Isotopes Inc. Common Stock (ASPI) grew revenue by 857.0% over the past year. This is strong growth.

ASP Isotopes Inc. Common Stock (ASPI) reported a net loss of $105.6M for fiscal year 2024.

Dividend & Returns

Yes, ASP Isotopes Inc. Common Stock (ASPI) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.

ASP Isotopes Inc. Common Stock (ASPI) has a return on equity (ROE) of -92.4%. Negative ROE indicates the company is unprofitable.

ASP Isotopes Inc. Common Stock (ASPI) had negative free cash flow of $34.0M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener